BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2295 related articles for article (PubMed ID: 32004974)

  • 1. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S; Zhang Y; Huang C; Lin S
    J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-Expression of miR-21 and Lower PTEN Levels in Wilms' Tumor with Aggressive Behavior.
    Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
    Tohoku J Exp Med; 2017 May; 242(1):43-52. PubMed ID: 28529243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
    Han S; Chen Y; Gao Y; Sun B; Kong Y
    Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM; Wu QM; Chang LY; Liu JC
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling.
    Wang B; Wang D; Yan T; Yuan H
    Exp Cell Res; 2016 Jul; 345(2):199-205. PubMed ID: 27207584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
    Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 115.